TSX VENTURE EXCHANGE: BOT
QUEBEC CITY, QC, Nov. 29, 2011 /CNW/ - Botaneco Corp. ("Botaneco" or the
"Corporation") (TSX Venture Exchange: BOT), announces that effective
immediately Mr. Aki Georgacacos has been appointed President and Chief
Executive Officer (CEO), replacing Mike Stangel. Mr. Georgacacos is a
member of the Botaneco's Board of Directors and a Partner in Avrio
Ventures, Canada's largest agriculture and agritech focused venture
capital fund. Mr. Georgacacos will act as President and CEO on an
interim basis while the Corporation evaluates alternatives to fill the
role on a permanent basis.
"Having been involved with the business since 2006, Aki will move
seamlessly into the President and CEO role," commented Dave Guebert,
the lead independent director of Botaneco.
Mr. Guebert added, "We'd like to thank Mike for the energy, and
leadership he has provided for the Company. He has been integral in
stabilizing operations and creating a diversified consumer health
products platform poised for continued growth."
Botaneco Corp., which includes its subsidiary Botaneco Specialty
Ingredients Inc. since November 20, 2009 and its subsidiary Natunola
Health Biosciences Inc. ("Natunola") since October 7, 2011, is a health sciences and technology company
developing, manufacturing and marketing proprietary natural ingredients
and formulations for oral and topical applications that have been
clinically proven to be safe and effective for improving skin health
and well being. More information is available and can be accessed at www.botaneco.ca
Neither TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
SOURCE Botaneco Corp.
For further information: